Definition: Disease modifying treatments are a group of drugs that impact the course of multiple sclerosis (MS) by slowing the progression of the disease and decreasing the number of relapses. The disease-modifying drugs are: Avonex, Betaseron, Copaxone, Novantrone, Rebif and Tysabri.

